U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H23ClN6O2S
Molecular Weight 519.018
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SETIPAFANT

SMILES

COC1=CC=C(NC(=O)N2CCC3=C(C2)SC4=C3C(=NCC5=NN=C(C)N45)C6=CC=CC=C6Cl)C=C1

InChI

InChIKey=DDJKTQDAEYPACV-UHFFFAOYSA-N
InChI=1S/C26H23ClN6O2S/c1-15-30-31-22-13-28-24(18-5-3-4-6-20(18)27)23-19-11-12-32(14-21(19)36-25(23)33(15)22)26(34)29-16-7-9-17(35-2)10-8-16/h3-10H,11-14H2,1-2H3,(H,29,34)

HIDE SMILES / InChI

Molecular Formula C26H23ClN6O2S
Molecular Weight 519.018
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Setipafant [BN 50727], triazolothienodiazepine, is a synthetic platelet activating factor antagonist that was under development with Beaufour-Ipsen for the treatment of diarrhoea, inflammatory bowel diseases, peptic ulcer and ulcerative colitis. The research has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
1992 Apr
Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets.
1996 Dec
Escherichia coli hemolysin and Staphylococcus aureas alpha-toxin potently induce neutrophil adhesion to cultured human endothelial cells.
1996 Nov 1
Patents

Patents

Sample Use Guides

Piglets: animals were separated into six groups: U4, controls; S, sham operated animals undergoing laparotomy; I4 and I9, ligation of the mesenteric vessels in the last ileal loop; IT4 and IT9, same procedure together with treatment with Setipafant (50 mg/kg) orally before and after surgery and intraperitoneally during surgery.
Route of Administration: Other
In Vitro Use Guide
Rabbit corneas were incubated with or without 500 nM PAF. PAF antagonist Setipafant [BN 50727] (10 uM) was added 10 min before PAF and the epithelium scraped and homogenated.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:19:29 GMT 2023
Edited
by admin
on Fri Dec 15 16:19:29 GMT 2023
Record UNII
UFN2Q54HS6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SETIPAFANT
INN  
INN  
Official Name English
setipafant [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID90157552
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
SMS_ID
100000084342
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
PUBCHEM
65968
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
MESH
C067429
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
NCI_THESAURUS
C76402
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107078
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
EVMPD
SUB10502MIG
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
CAS
132418-35-0
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
FDA UNII
UFN2Q54HS6
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
INN
7287
Created by admin on Fri Dec 15 16:19:29 GMT 2023 , Edited by admin on Fri Dec 15 16:19:29 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY